Yale Bulletin and Calendar

December 2, 2005|Volume 34, Number 13|Two-Week Issue


BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

DOWNLOAD FORMS

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Study illuminates the role of
specific cells in antibody response

A report in the Nov. 17 issue of Nature by School of Medicine researchers emphasizes which cells are important in mounting an antibody response to invading microbes.

It now appears that, in order to elicit good antibody responses, successful vaccines must incorporate activation ligands for the Toll like receptors (TLRs) of both B cells and dendritic cells, says Ruslan Medzhitov, professor in the Section of Immunobiology, a Howard Hughes Medical Institute investigator and lead author of the study.

One way the immune system combats infection is with antibodies, targeting molecules that are secreted by B cells, a type of white blood cell. To produce antibodies, B cells interact with other immune system cells, helper T cells, which are activated by dendritic cells that have detected microbial infection through their TLRs. Although B cells have their own TLRs, until this study, their role was a mystery.

Chandrashekhar Pasare, an associate research scientist in Medzhitov's laboratory, examined the importance of the B cell TLRs and dendritic cells for sensing microbes. The researchers found the expected antibody production by B cells from dendritic cell activated T cells. "However, we found that B cells also needed to sense microbes via their own TLRs for optimal production of antibodies," Pasare says.

"Until now, it was thought that B cell activation was controlled by the helper T cells, and helper T cells were in turn controlled by dendritic cells," Medzhitov says. "The emphasis of the field was on the dendritic cell recognizing the microbes via their TLRs and not the lymphocytes."

The researchers say the results of this study may also shed light on both the pathogenesis and treatment of autoimmune diseases mediated by B cells, such as lupus or myasthenia gravis.

-- By Jacqueline Weaver


T H I SW E E K ' SS T O R I E S

Yale and Peking University students . . . in new exchange program

Seven seniors Britain-bound as winners of Rhodes and Marshall Scholarships

Students spent Thanksgiving break helping Katrina victims

New center will foster cutting-edge neuroscience research

Grant supports study of how the aged recover

ENDOWED PROFESSORSHIPS

Global terrorism is focus of talk by Major and Zedillo

Come Harvest Time at Yale's organic garden

Study finds ADHD drug reduces hyperactivity in children with PDD

Study illuminates the role of specific cells in antibody response

Clinical study tests drug combination for ovarian cancer

Symposium on nuclear physics honors . . . D. Allan Bromley

Conference honors faculty members for service to the University

Emilie Townes elected vice president of AAR

Not-So-Hidden Treasures for gift-seekers at Yale's museum shops

Holiday gifts at 'Alternative Market' help people in need

University expands its nighttime 'minibus' services

Gallery's new artist-in-residence aims to connect viewers with nature

Event to feature companies whose products are based on Yale research

David Brion Davis Lecture Series examines legacy of abolitionism

First BioHaven Entrepreneurship Seminar to take place Dec. 13

Memorial service for Boris I. Bittker

Yale Books in Brief

Campus Notes


Bulletin Home|Visiting on Campus|Calendar of Events|In the News

Bulletin Board|Classified Ads|Search Archives|Deadlines

Bulletin Staff|Public Affairs|News Releases| E-Mail Us|Yale Home